Barrier Reverse Convertible

    BioNTech SE

    Coupon p.a.: 10.00%  |  Barrier: 55.63 USD  |  Currency: USD  |  Maturity: 05/05/2025

    %
    USD Nominal

    %
    USD Nominal

    Spread

    BioNTech SE: 112.19 USD|Last Update:

    Product Overview

    Key figures

    Coupon (Coupon p.a.)
    		10.0556% (10.00%)
    Accrued Interest
    		6.86% (68.611 USD)
    Yield Max
    		1.77%
    Yield Max p.a.
    		5.46%
    Strike
    		92.72 USD
    Barrier
    		55.63 USD (60.00%)
    Distance to Barrier
    		50.41%
    Ratio
    		10.78516

    Life Cycle

    • Initial Fixing
    • First trading day
    • Today
    • Last trading date
    • Final fixing
    • Redemption
    GraphUnderlyingPrice (indicative)Last Closing Price (indicative)Performance
    -BioNTech SEPrice (indicative)
    		Last Closing Price (indicative)112.1871 USDPerformance-1.35%

    Product Information

    About this product

    Barrier Reverse Convertibles (BRCs) are structured products, which are characterized by a fixed coupon and a certain safety buffer. As a result, investors are protected against price setbacks up to the barrier, while the profit potential is limited to the coupon.

    Stay updated

    Subscribe to receive information about structured products

    Your personal data will be processed to provide information as per Vontobel Privacy Policy.

    newletter overlay image

    Stay updated

    Subscribe to receive information about structured products

    Your personal data will be processed to provide information as per Vontobel Privacy Policy.

    Vontobel Markets – Bank Vontobel AG and/or affiliates. All rights reserved.

    Please read this information before continuing, as products and services contained on this website are not accessible to certain persons. The information and/or documents offered on this website represent marketing material pursuant to Art. 68 of the Swiss FinSA and are provided for information purposes only. On request, further documents such as the key information document or the prospectus/issue documentation are available free of charge whenever you wish.